MBOT Stock Chart & Stats
$1.71
-$0.05(-2.84%)
At close: 4:00 PM EDT
$1.71
-$0.05(-2.84%)
Day’s Range― - ―
52-Week Range$1.45 - $4.67
Previous CloseN/A
Volume369.66K
Average Volume (3M)705.46K
Market Cap
$104.11M
Enterprise Value$82.91M
Total Cash (Recent Filing)$67.37M
Total Debt (Recent Filing)$876.00K
Price to Earnings (P/E)―
Beta1.39
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.26
Shares Outstanding67,164,800
10 Day Avg. Volume529,004
30 Day Avg. Volume705,457
Financial Highlights & Ratios
PEG Ratio0.11
Price to Book (P/B)1.18
Price to Sales (P/S)0.00
P/FCF Ratio-6.99
Enterprise Value/Market Cap0.80
Enterprise Value/Revenue239.63
Enterprise Value/Gross Profit-129.35
Enterprise Value/Ebitda-5.09
Forecast
1Y Price Target
$8.00Price Target Upside367.84% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)-0.29
Revenue Forecast (FY)$2.66M
Microbot Medical News
MBOT FAQ
What was Microbot Medical’s price range in the past 12 months?
Microbot Medical lowest stock price was $1.45 and its highest was $4.67 in the past 12 months.
What is Microbot Medical’s market cap?
Microbot Medical’s market cap is $104.11M.
When is Microbot Medical’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Microbot Medical’s earnings last quarter?
Microbot Medical released its earnings results on Apr 14, 2020. The company reported -$0.31 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.31.
Is Microbot Medical overvalued?
According to Wall Street analysts Microbot Medical’s price is currently Undervalued.
Does Microbot Medical pay dividends?
Microbot Medical does not currently pay dividends.
What is Microbot Medical’s EPS estimate?
Microbot Medical’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Microbot Medical have?
Microbot Medical has 67,164,800 shares outstanding.
What happened to Microbot Medical’s price movement after its last earnings report?
Microbot Medical reported an EPS of -$0.31 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Microbot Medical?
Currently, no hedge funds are holding shares in MBOT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Microbot Medical Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$8.00 (367.84% Upside)
$8.00 (367.84% Upside)
Blogger Sentiment
Neutral
MBOT Sentiment 50%
Sector Average 61%
Sector Average 61%
Hedge Fund Trend
Decreased
By 16.3K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.6%
Last 30 Days ▼ 2.6%
Last 30 Days ▼ 2.6%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-37.59%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
121.44%
Trailing 12-Months
Company Description
Microbot Medical
Microbot Medical Inc. operates as a pre-clinical stage medical device company, concentrating its efforts on the research, design, and development of robotic instruments for endoluminal surgery, specifically targeting the field of minimally invasive procedures. Leveraging its proprietary micro-robotic technologies, which include ViRob, TipCAT, CardioSert, and Liberty, the company is actively developing several key products. These include a Self-Cleaning Shunt intended for the treatment of hydrocephalus and normal pressure hydrocephalus, as well as a single-use robotic system designed for various endovascular interventional applications. Additionally, Microbot Medical maintains a robust, multi-generational product pipeline. Its global intellectual property portfolio is substantial, encompassing 42 granted or allowed patents and an additional 23 patent applications currently under review. The company also benefits from a strategic collaboration agreement with Stryker Corporation, focusing on joint technology development. Established in 2010, Microbot Medical Inc. is headquartered in Hingham, Massachusetts.
MBOT Stock 12 Month Forecast
Average Price Target
$8.00
▲(367.84% Upside)
Technical Analysis
Ownership Overview
0.20%
Insiders
5.85% Mutual Funds
1.83% Other Institutional Investors
87.30% Public Companies and
Individual Investors